Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tianmeng Oral Liquid (TMOL) is a traditional Chinese medicine (TCM) compound preparation composed of seventeen herbal ingredients, including *Acanthopanax senticosus*, *Polygonatum sibiricum*, *Rehmannia glutinosa*, *Lycium chinense*, *Fructus Mori*, *Epimedium brevicornu*, *Silkworm moth*, *Astragalus membranaceus*, and *Codonopsis pilosula*. Formulated according to the classical 'Jun-Chen-Zuo-Shi' principles, it is primarily indicated for the treatment of insomnia, particularly cases caused by deficiency of the spleen and kidney. As a multi-component herbal formulation, TMOL exhibits a multi-target pharmacological profile that modulates central nervous system activity, neuroendocrine regulation, and immune homeostasis. Beyond primary insomnia, it has been investigated for anxiety, depressive symptoms, psychosomatic disorders, and as an adjunct therapy for post-stroke insomnia and antipsychotic-induced side effects in patients with schizophrenia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tianmeng Oral Liquid.